Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2020 | 03-2019 | 03-2018 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 18 | 21 | 18 |
| Accounts receivable | 361 | 454 | -213 |
| Accounts payable and accrued liabilities | N/A | 82 | 456 |
| Other Working Capital | 444 | 307 | 155 |
| Other Operating Activity | -5,084 | -4,320 | -3,720 |
| Operating Cash Flow | $-4,260 | $-3,457 | $-3,304 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1 | -13 | -53 |
| Purchase Of Investment | 0 | 0 | -10 |
| Investing Cash Flow | $-1 | $-13 | $-63 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 242 | 73 | 570 |
| Debt Repayment | -53 | -24 | 0 |
| Common Stock Issued | 7,948 | 0 | 7,424 |
| Other Financing Activity | 1,225 | 3,009 | -358 |
| Financing Cash Flow | $9,361 | $3,058 | $7,636 |
| Exchange Rate Effect | -11 | 112 | 112 |
| Beginning Cash Position | 5,421 | 5,722 | 1,340 |
| End Cash Position | 10,510 | 5,421 | 5,722 |
| Net Cash Flow | $5,100 | $-412 | $4,269 |
| Free Cash Flow | |||
| Operating Cash Flow | -4,260 | -3,457 | -3,304 |
| Capital Expenditure | -1 | -13 | -53 |
| Free Cash Flow | -4,261 | -3,470 | -3,357 |